down arrow

Ultragenyx Pharmaceutical, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US90400D1081
USD
36.54
3.07 (9.17%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
255.30
275.41
352.49
922.56
1,154.38
653.76
Shareholder's Funds
255.30
275.41
352.49
922.56
1,154.38
653.76
Minority Interest
7.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
879.97
904.16
887.22
362.85
344.64
322.60
Secured Loans
879.97
904.16
887.22
362.85
344.64
322.60
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
30.06
30.06
31.67
33.31
33.31
33.31
Other Long Term Liabilities
77.18
78.8
62.44
75.62
113.25
70.73
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
897.01
941.12
937.88
427.41
448.92
386.09
Current Liabilities
Trade Payables
38.76
42.11
43.27
17.14
12.92
12.87
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
344.15
280.44
261.21
181.37
189.61
103.30
Total Liabilities
1,503.46
1,496.97
1,551.59
1,531.34
1,792.90
1,143.16
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
403.91
397.87
349.07
226.22
151.43
100.66
Less: Accumulated Depreciation
112.48
83.40
63.38
50.04
37.39
25.99
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
291.43
314.47
285.69
176.18
114.04
74.68
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
138.63
203.71
158.30
296.36
169.90
35.42
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
33.56
29.98
13.05
18.06
4.79
0.97
Total Non-Current Assets
686.33
764.79
667.69
674.73
497.60
292.14
Current Assets Loans & Advances
Current Investments
436.30
363.62
614.82
432.61
488.01
321.65
Inventories
45.01
33.97
26.77
16.23
13.05
11.55
Sundry Debtors
121.80
73.39
40.45
28.43
49.09
32.84
Cash and Bank
180.53
215.59
133.81
307.58
724.37
433.75
Other Current Assets
785.44
687.68
822.24
800.86
1,274.52
799.78
Short Term Loans and Advances
1.80
1.10
6.40
16.00
0.00
0.00
Total Current Assets
817.12
732.18
883.90
856.60
1,295.30
851.02
Net Current Assets (Including Current Investments)
472.97
451.75
622.69
675.24
1,105.70
747.72
Total Current Assets Excluding Current Investments
817.12
732.18
883.90
856.60
1,295.30
851.02
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,503.46
1,496.97
1,551.59
1,531.34
1,792.90
1,143.16
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
879.97
904.16
887.22
362.85
344.64
322.60
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is -4.93% vs -1.50% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is -2.06% vs 26.20% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -7.33% vs 10.07% in Dec 2023

stock-summary

Investments

YoY Growth in year ended Dec 2024 is -31.95% vs 28.69% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 11.60% vs -17.16% in Dec 2023

Compare Balance Sheet Results of Ultragenyx Pharmaceutical, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
255.30
750.11
-494.81
-65.96%
Shareholder's Funds
255.30
750.11
-494.81
-65.96%
Minority Interest
7.00
0
7.00
0.00%
Long-Term Borrowings
879.97
35.59
844.38
2,372.52%
Secured Loans
879.97
35.59
844.38
2,372.52%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
30.06
0
30.06
0.00%
Other Long Term Liabilities
77.18
0.72
76.46
10,619.44%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
897.01
36.02
860.99
2,390.31%
Current Liabilities
Trade Payables
38.76
9.03
29.73
329.24%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
344.15
39.75
304.40
765.79%
Total Liabilities
1,503.46
825.89
677.57
82.04%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
403.91
0
403.91
0.00%
Less: Accumulated Depreciation
112.48
0
112.48
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
291.43
0.76
290.67
38,246.05%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
138.63
54.75
83.88
153.21%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
33.56
0
33.56
0.00%
Total Non-Current Assets
686.33
55.51
630.82
1,136.41%
Current Assets Loans & Advances
Current Investments
436.30
402.84
33.46
8.31%
Inventories
45.01
0
45.01
0.00%
Sundry Debtors
121.80
0
121.80
0.00%
Cash and Bank
180.53
340.24
-159.71
-46.94%
Other Current Assets
785.44
743.08
42.36
5.70%
Short Term Loans and Advances
1.80
0
1.80
0.00%
Total Current Assets
817.12
770.38
46.74
6.07%
Net Current Assets (Including Current Investments)
472.97
730.63
-257.66
-35.27%
Total Current Assets Excluding Current Investments
817.12
770.38
46.74
6.07%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
1,503.46
825.89
677.57
82.04%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
879.97
35.59
844.38
2,372.52%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 819.82 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -4.93% vs -1.50% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 77.18 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -2.06% vs 26.20% in Dec 2023

Annual - Fixed Assets
Fixed Assets 291.43 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -7.33% vs 10.07% in Dec 2023

Annual - Investments
Investments 138.63 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -31.95% vs 28.69% in Dec 2023

Annual - Current Assets
Current Assets 817.12 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.60% vs -17.16% in Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."